Dr. Jacob Inda, MD

NPI: 1275997827
Total Payments
$1,488
2024 Payments
$170.96
Companies
15
Transactions
62
Medicare Patients
4,822
Medicare Billing
$276,118

Payment Breakdown by Category

Food & Beverage$1,488 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,488 62 100.0%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $472.98 26 $0 (2024)
Galderma Laboratories, L.P. $219.84 1 $0 (2021)
Novartis Pharmaceuticals Corporation $143.19 8 $0 (2022)
Boehringer Ingelheim Pharmaceuticals, Inc. $125.00 1 $0 (2023)
GENZYME CORPORATION $97.52 5 $0 (2024)
UCB, Inc. $76.86 3 $0 (2023)
Lilly USA, LLC $75.75 4 $0 (2023)
Janssen Biotech, Inc. $55.08 3 $0 (2023)
Amgen Inc. $52.69 2 $0 (2023)
LEO Pharma Inc. $43.06 2 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $170.96 12 ABBVIE INC. ($130.89)
2023 $627.06 25 ABBVIE INC. ($322.82)
2022 $239.52 12 Novartis Pharmaceuticals Corporation ($72.01)
2021 $450.46 13 Galderma Laboratories, L.P. ($219.84)

All Payment Transactions

62 individual payment records from CMS Open Payments — Page 3 of 3

Date Company Product Nature Form Amount Type
12/13/2021 Novartis Pharmaceuticals Corporation COSENTYX (Biological) Food and Beverage In-kind items and services $17.28 General
Category: IMMUNOLOGY
11/23/2021 LEO Pharma Inc. ENSTILAR (Drug) Food and Beverage In-kind items and services $15.12 General
Category: DERMATOLOGY
11/17/2021 Novartis Pharmaceuticals Corporation COSENTYX (Biological) Food and Beverage In-kind items and services $24.30 General
Category: IMMUNOLOGY
10/21/2021 AbbVie Inc. SKYRIZI (Biological) Food and Beverage In-kind items and services $19.27 General
Category: IMMUNOLOGY
10/13/2021 Incyte Corporation OPZELURA (Drug) Food and Beverage Cash or cash equivalent $22.10 General
Category: Dermatology
10/06/2021 Ortho Dermatologics, a division of Bausch Health US, LLC ARAZLO (Drug) Food and Beverage In-kind items and services $24.98 General
Category: Dermatology
10/05/2021 Lilly USA, LLC TALTZ (Drug) Food and Beverage In-kind items and services $14.39 General
Category: Immunology
09/29/2021 Novartis Pharmaceuticals Corporation COSENTYX (Biological) Food and Beverage In-kind items and services $16.43 General
Category: IMMUNOLOGY
09/15/2021 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $14.56 General
Category: INFLAMMATION AND IMMUNOLOGY
09/10/2021 Galderma Laboratories, L.P. Food and Beverage In-kind items and services $219.84 General
08/25/2021 UCB, Inc. Cimzia (Drug) Food and Beverage In-kind items and services $28.84 General
Category: Immunology
08/18/2021 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $20.18 General
Category: Immunology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 12 2,660 3,856 $488,965 $175,813
2022 11 1,103 1,559 $192,973 $62,938
2021 10 771 1,211 $132,080 $27,363
2020 6 288 415 $38,372 $10,004
Total Patients
4,822
Total Services
7,041
Medicare Billing
$276,118
Procedure Codes
56

All Medicare Procedures & Services

56 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 441 441 $86,436 $29,204 33.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 340 407 $64,306 $25,448 39.6%
11102 Biopsy of related skin growth, first growth Office 2023 327 350 $59,278 $24,348 41.1%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 229 229 $68,013 $24,151 35.5%
17000 Destruction of precancer skin growth, 1 growth Office 2023 480 551 $63,492 $20,927 33.0%
17110 Destruction of skin growth, 1-14 growths Office 2023 223 248 $49,837 $20,046 40.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 161 200 $44,600 $17,337 38.9%
17003 Destruction of precancer skin growth, 2-14 growths Office 2023 342 1,276 $33,176 $6,063 18.3%
11103 Biopsy of related skin growth, each additional growth Office 2023 71 106 $10,282 $4,156 40.4%
11104 Punch biopsy, first skin growth Office 2023 17 19 $4,332 $1,849 42.7%
17261 Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm Office 2023 15 15 $3,828 $1,689 44.1%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 14 14 $1,386 $593.32 42.8%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 152 152 $29,716 $10,554 35.5%
11102 Biopsy of related skin growth, first growth Office 2022 116 117 $21,012 $7,396 35.2%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 62 62 $18,428 $7,375 40.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 111 116 $16,848 $6,855 40.7%
17000 Destruction of precancer skin growth, 1 growth Office 2022 173 176 $22,921 $6,846 29.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 58 65 $13,993 $6,247 44.6%
17110 Destruction of skin growth, 1-14 growths Office 2022 71 76 $15,478 $5,460 35.3%
99203 New patient office or other outpatient visit, 30-44 minutes Facility 2022 40 40 $7,880 $2,083 26.4%
17003 Destruction of precancer skin growth, 2-14 growths Office 2022 137 493 $14,347 $2,071 14.4%
11103 Biopsy of related skin growth, each additional growth Office 2022 27 47 $4,629 $1,709 36.9%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2022 36 37 $4,884 $1,675 34.3%
11104 Punch biopsy, first skin growth Office 2022 12 14 $2,836 $1,164 41.1%
17000 Destruction of precancer skin growth, 1 growth Facility 2022 33 33 $5,379 $1,100 20.5%

About Dr. Jacob Inda, MD

Dr. Jacob Inda, MD is a Dermatology healthcare provider based in Missoula, Montana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/10/2016. The National Provider Identifier (NPI) number assigned to this provider is 1275997827.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jacob Inda, MD has received a total of $1,488 in payments from pharmaceutical and medical device companies, with $170.96 received in 2024. These payments were reported across 62 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($1,488).

As a Medicare-enrolled provider, Inda has provided services to 4,822 Medicare beneficiaries, totaling 7,041 services with total Medicare billing of $276,118. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.

Practice Information

  • Specialty Dermatology
  • Location Missoula, MT
  • Active Since 04/10/2016
  • Last Updated 10/04/2022
  • Taxonomy Code 207N00000X
  • Entity Type Individual
  • NPI Number 1275997827

Products in Payments

  • SKYRIZI (Biological) $254.54
  • RINVOQ (Biological) $218.44
  • COSENTYX (Biological) $143.19
  • DUPIXENT (Biological) $127.00
  • SPEVIGO (Drug) $125.00
  • Cimzia (Drug) $76.86
  • TALTZ (Drug) $75.75
  • Otezla (Drug) $52.69
  • OPZELURA (Drug) $36.95
  • REMICADE (Biological) $33.33
  • ADBRY (Biological) $27.94
  • ARAZLO (Drug) $24.98
  • TREMFYA (Drug) $21.75
  • Puraply (Medical Supply) $17.44
  • ENSTILAR (Drug) $15.12

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Dermatology Doctors in Missoula